ADX-47273
ADX-47273 is a research pharmaceutical developed by Addex Therapeutics which acts as a positive allosteric modulator (PAM) selective for the metabotropic glutamate receptor subtype mGluR 5 .
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
ADX-47273 is a research pharmaceutical developed by Addex Therapeutics which acts as a positive allosteric modulator (PAM) selective for the metabotropic glutamate receptor subtype mGluR 5 . It has nootropic and antipsychotic effects in animal studies, and has been used as a lead compound to develop improved derivatives.
See also
Dipraglurant Raseglurant
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330121340 under CC BY-SA 4.0; modifications have been made.